STOCKS ARE NOW LOWER ACROSS THE BOARD AS EARNINGS FAIL TO ROUSE INVESTORS
STOCKS TRY TO PUSH TO NEW RECORD HIGHS WEDNESDAY FOLLOWING MIXED EARNINGS NEWS
BOEING STOCK SWINGS HIGHER AFTER EARNINGS, WHICH INCLUDED COSTS FOR 737 MAX
NEED TO KNOW: LATEST STOCK-MARKET RECORDS COULD BE A HEAD FAKE, ANALYST WARNS
BOEING'S STOCK SLIPS AFTER PROFIT MISSES, GUIDANCE DELAYED
OCCIDENTAL SWEEPS IN WITH HIGHER BID FOR ANADARKO THAN CHEVRON IS OFFERING
AT&T SHARES SLIDE AFTER COMPANY'S REVENUE MISSES WALL STREET EXPECTATIONS
WHITE HOUSE MISSES DEADLINE TO TURN OVER TRUMP TAXES TO CONGRESS
TRUMP MET WITH TWITTER CEO JACK DORSEY TODAY TWTR
EBAY STOCK UP 4% AFTER EARNINGS TOP ESTIMATES EBAY

Medical Diagnostics & Research Industry Stocks 0


Screener
Min must be less than the Max.
Name PRICE MARKET CAPITALIZATION PRICE TO EARNINGS RATIO DIVIDEND YIELD SYMBOL EXCHANGE PRICE PERCENT DIFFERENCE YEAR TO DATE PRICE PERCENT DIFFERENCE 5 YEAR CHART 1 YEAR CHART

Anixa Biosciences, Inc. - Common Stock

ANIX $4.25
-0.01 (-0.23%)

ANIX Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 80 Million
ANIX Description

Anixa Biosciences Inc, a cancer-focused biotechnology company, is engaged in harnessing body's immune system in the fight against cancer. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. It is developing the CchekTM platform, a series of inexpensive non-invasive blood tests for early detection of solid tumors which is based on the body's immune response to the presence of a malignancy. It is also developing chimeric antigen receptor T-cell (CAR-T) based immuno-therapy drugs which genetically engineer a patient's own immune cells to fight cancer. The company also examines emerging technologies in complementary or related fields for further development and commercialization. http://www.anixa.com

ANIX Earnings

EPS -0.25 P/E Ratio 0.00
Previous Earnings --
Latest Earnings Mon, Jul 30, 2018 (268 days ago)

ANIX Dividend

Dividend --
Ex-Date --
Pay Date --
History --

ANIX Charts

$3.02
52 Week Range
$6.59
Jun 25, 2018
Oct 17, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

4.25 0.08 0.00 0.00 ANIX NASDAQ -0.23 7.59 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ANIX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ANIX&exchange=NASDAQ&chart=1

American Renal Associates Holdings Inc

ARA $6.58
+0.03 (0.46%)

ARA Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 200 Million
ARA Description

American Renal Associates Holdings Inc is a joint venture-focused dialysis services provider in the United States. The company through its subsidiary is engaged in providing kidney dialysis services for patients suffering from chronic kidney failure, also known as end-stage renal disease. The company operates nearly 217 dialysis clinics in around 25 states and Washington, D.C. It also offers outpatient and inpatient dialysis treatments for patients suffering from chronic kidney failure. http://www.americanrenal.com

ARA Earnings

EPS 0.06 P/E Ratio 0.00
Previous Earnings Thu, Nov 8, 2018
Latest Earnings Fri, Mar 8, 2019 (47 days ago)

ARA Dividend

Dividend --
Ex-Date --
Pay Date --
History --

ARA Charts

$5.84
52 Week Range
$22.84
Apr 16, 2019
Oct 1, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

6.58 0.20 0.00 0.00 ARA NYSE 0.46 -44.84 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ARA&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ARA&exchange=NYSE&chart=1

Atossa Genetics Inc

ATOS $3.38
-0.10 (-2.87%)

ATOS Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 30 Million
ATOS Description

Atossa Genetics Inc is a clinical-stage pharmaceutical company operating in the US. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The clinical-Stage Programs of the company includes delivery of therapeutics through microcatheters which delivers a number of therapeutics to the ducts in the breast, the site of the majority of early breast cancers and fulvestrant Delivered through microcatheters which delivers fulvestrant as a potential treatment of ductal carcinoma in-situ (DCIS) and breast cancer. In addition, the company involves in the process of evaluating additional potential indications of endoxifen and other therapeutic candidates to treat breast conditions, including breast cancer. https://www.atossagenetics.com

ATOS Earnings

EPS 0.21 P/E Ratio 0.00
Previous Earnings --
Latest Earnings --

ATOS Dividend

Dividend --
Ex-Date --
Pay Date --
History --

ATOS Charts

$0.92
52 Week Range
$7.07
Dec 26, 2018
Mar 14, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

3.38 0.03 0.00 0.00 ATOS NASDAQ -2.87 191.38 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ATOS&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ATOS&exchange=NASDAQ&chart=1

Accelerate Diagnostics Inc

AXDX $18.20
-0.06 (-0.33%)

AXDX Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 1.02 Billion
AXDX Description

Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. http://www.acceleratediagnostics.com

AXDX Earnings

EPS -0.41 P/E Ratio 0.00
Previous Earnings Tue, Nov 6, 2018
Latest Earnings Tue, Feb 19, 2019 (64 days ago)

AXDX Dividend

Dividend --
Ex-Date --
Pay Date --
History --

AXDX Charts

$10.42
52 Week Range
$24.60
Dec 21, 2018
Aug 31, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

18.20 1.02 0.00 0.00 AXDX NASDAQ -0.33 53.07 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AXDX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=AXDX&exchange=NASDAQ&chart=1

Bioanalytical Systems Inc

BASI $1.99
+0.03 (1.53%)

BASI Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 20 Million
BASI Description

Bioanalytical Systems Inc is a contract research organization which provides drug discovery and development services and analytical instruments. The company operates in two business segments namely contract research services and research products. The contract research services segment provides research and development support on a contract basis directly to pharmaceutical companies. In addition, it also includes services to screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance and quality control testing. The research products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers, and medical research institutions. http://www.basinc.com

BASI Earnings

EPS -0.01 P/E Ratio 0.00
Previous Earnings --
Latest Earnings --

BASI Dividend

Dividend --
Ex-Date --
Pay Date --
History --

BASI Charts

$1.22
52 Week Range
$2.10
Dec 26, 2018
Apr 2, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

1.99 0.02 0.00 0.00 BASI NASDAQ 1.53 48.51 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BASI&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BASI&exchange=NASDAQ&chart=1

BioTelemetry Inc

BEAT $59.34
+0.77 (1.31%)

BEAT Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 1.87 Billion
BEAT Description

BioTelemetry Inc provides monitoring services and digital population health management for healthcare providers, medical device manufacturing, and centralized core laboratory services for clinical research. It operates under healthcare, technology, and research segments. The Healthcare segment is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Research segment is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials and the Technology segment, focuses on the development, manufacturing, testing, and marketing of cardiovascular and blood glucose monitoring devices to medical companies, clinics and hospitals. https://www.gobio.com

BEAT Earnings

EPS 0.31 P/E Ratio 148.00
Previous Earnings Thu, Feb 21, 2019
Latest Earnings Thu, Apr 25, 2019 (In 1 days)

BEAT Dividend

Dividend --
Ex-Date --
Pay Date --
History --

BEAT Charts

$33.30
52 Week Range
$77.59
Apr 24, 2018
Feb 15, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

59.34 1.87 148.00 0.00 BEAT NASDAQ 1.31 0.00 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BEAT&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BEAT&exchange=NASDAQ&chart=1

Bio-Rad Laboratories Inc

BIO $293.91
-1.23 (-0.42%)

BIO Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 8.77 Billion
BIO Description

Bio-Rad Laboratories Inc manufactures and supplies systems used to separate and analyze chemical and biological materials to life sciences and healthcare companies. The firm has two business segments: Life Science and Clinical Diagnostics. The life sciences segment manufactures reagents and laboratory instruments used by researchers, food producers, and pharmaceutical manufacturers. The Clinical Diagnostics segment generates over half of the firm's revenue and sells in vitro diagnostic tests to clinical laboratories. Most of the firm's revenue is generated from the United States. http://www.bio-rad.com

BIO Earnings

EPS -27.88 P/E Ratio 25.69
Previous Earnings Thu, Feb 28, 2019
Latest Earnings Wed, May 8, 2019 (In 14 days)

BIO Dividend

Dividend --
Ex-Date --
Pay Date --
History --

BIO Charts

$220.10
52 Week Range
$326.15
Dec 24, 2018
Sep 4, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

293.91 8.77 25.69 0.00 BIO NYSE -0.42 28.86 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BIO&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BIO&exchange=NYSE&chart=1

Biocept Inc

BIOC $0.87
-0.08 (-8.42%)

BIOC Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 20 Million
BIOC Description

Biocept Inc is an early commercial-stage molecular oncology diagnostics company. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA assays utilizing a standard blood sample. The company's lung, breast, and gastric cancer assays provide information to oncologists and other physicians that enable them to select personalized treatment for their patients based on detailed data on the characteristics of tumors. Its products include CEE-Sure BCT, and Target Selector Kits. Geographically, it operates through the United States, which is also the revenue generation region for the group. https://www.biocept.com

BIOC Earnings

EPS -1.43 P/E Ratio 0.00
Previous Earnings --
Latest Earnings --

BIOC Dividend

Dividend --
Ex-Date --
Pay Date --
History --

BIOC Charts

$0.69
52 Week Range
$8.01
Dec 17, 2018
Jun 18, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

0.87 0.02 0.00 0.00 BIOC NASDAQ -8.42 -11.22 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BIOC&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BIOC&exchange=NASDAQ&chart=1

Biomerica Inc

BMRA $2.39
-0.02 (-0.58%)

BMRA Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 20 Million
BMRA Description

Biomerica Inc is an Irvine, California based developer of diagnostic tests, including InFoods Diagnostic Guided Therapy now in development for the treatment of IBS. The company sells a suite of diagnostic products principally for the early detection and monitoring of gastrointestinal diseases, diabetes and food intolerances at the point-of-care and in-hospital/clinical laboratories. The company's products are designed to enhance the health and well being of people, while reducing total healthcare costs. http://www.biomerica.com

BMRA Earnings

EPS -0.07 P/E Ratio 0.00
Previous Earnings --
Latest Earnings Tue, Oct 16, 2018 (190 days ago)

BMRA Dividend

Dividend --
Ex-Date --
Pay Date --
History --

BMRA Charts

$1.70
52 Week Range
$4.21
Dec 31, 2018
Jun 1, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

2.39 0.02 0.00 0.00 BMRA NASDAQ -0.58 23.20 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BMRA&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BMRA&exchange=NASDAQ&chart=1

Bruker Corp

BRKR $37.94
+0.13 (0.34%)

BRKR Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 5.96 Billion
BRKR Description

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. The vast majority of revenue comes from the scientific instruments segment, which develops tools based on magnetic resonance, mass spectrometry, and X-ray technologies. The remainder of the firm's business comes from the energy and superconductor technology segment, which manufactures superconducting materials primarily used in magnetic resonance imaging, nuclear magnetic resonance, and fusion energy research. The largest proportion of Bruker's revenue comes from Europe, though the firm also has a significant presence in the United States and Asia. http://www.bruker.com

BRKR Earnings

EPS 0.50 P/E Ratio 34.70
Previous Earnings Thu, Nov 1, 2018
Latest Earnings Mon, Feb 11, 2019 (72 days ago)

BRKR Dividend

Dividend 0.42% / $0.16
Ex-Date Fri, Nov 30, 2018 (145 days ago)
Pay Date Fri, Dec 21, 2018
History 12 Payments (Quarterly)

BRKR Charts

$26.45
52 Week Range
$40.16
Dec 24, 2018
Mar 21, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

37.94 5.96 34.70 0.42 BRKR NASDAQ 0.34 29.49 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BRKR&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=BRKR&exchange=NASDAQ&chart=1

CareDx Inc

CDNA $26.83
+0.18 (0.68%)

CDNA Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 1.08 Billion
CDNA Description

CareDx Inc operates as a transplant diagnostics company, which offers pre- and post-transplant continuum. The company focuses on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic surveillance solutions for transplant patients. Its product includes AlloMap, which aids clinicians in identifying heart transplant recipients with stable allograft function and AlloSure, which is a donor-derived cell free DNA test. https://www.caredx.com

CDNA Earnings

EPS -0.09 P/E Ratio 0.00
Previous Earnings Thu, Nov 8, 2018
Latest Earnings Wed, Mar 6, 2019 (49 days ago)

CDNA Dividend

Dividend --
Ex-Date --
Pay Date --
History --

CDNA Charts

$9.35
52 Week Range
$39.21
Apr 24, 2018
Mar 21, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

26.83 1.08 0.00 0.00 CDNA NASDAQ 0.68 11.88 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CDNA&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CDNA&exchange=NASDAQ&chart=1

Celcuity Inc

CELC $21.25
+0.30 (1.43%)

CELC Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 210 Million
CELC Description

Celcuity Inc is active in the healthcare domain. It is a cellular analysis company that is discovering new cancer sub-types and commercialising diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The company's proprietary CELx diagnostic platform uses the patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that best treats it. http://www.celcuity.com

CELC Earnings

EPS -0.18 P/E Ratio 0.00
Previous Earnings Tue, Nov 13, 2018
Latest Earnings Tue, Feb 26, 2019 (57 days ago)

CELC Dividend

Dividend --
Ex-Date --
Pay Date --
History --

CELC Charts

$18.38
52 Week Range
$30.77
Mar 7, 2019
Sep 20, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

21.25 0.21 0.00 0.00 CELC NASDAQ 1.43 -7.04 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CELC&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CELC&exchange=NASDAQ&chart=1

Chembio Diagnostics Inc

CEMI $7.19
+0.07 (0.98%)

CEMI Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 120 Million
CEMI Description

Chembio Diagnostics Inc is a US-based company which develops, manufactures, and commercializes point-of-care diagnostic tests which detect infectious diseases. The products of the company include rapid tests for the detection of HIV 1/2 antibodies and a multiplex rapid test for the detection of HIV and syphilis antibodies. Most of the company's revenue comes from the sale of ASC 605. The company offered rapid medical tests are offered in Africa, Asia, Europe and Middle East, Latin America and the United States, of which key revenue is derived from the Latin America. http://www.chembio.com

CEMI Earnings

EPS -0.21 P/E Ratio 0.00
Previous Earnings Thu, Nov 8, 2018
Latest Earnings Thu, Mar 7, 2019 (48 days ago)

CEMI Dividend

Dividend --
Ex-Date --
Pay Date --
History --

CEMI Charts

$4.95
52 Week Range
$11.50
Dec 24, 2018
Aug 1, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

7.19 0.12 0.00 0.00 CEMI NASDAQ 0.98 27.03 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CEMI&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CEMI&exchange=NASDAQ&chart=1

Cancer Genetics Inc

CGIX $0.23
-0.01 (-4.17%)

CGIX Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 10 Million
CGIX Description

Cancer Genetics Inc is in the early stage of precision medicine, enabling individualized therapies in the field of oncology through diagnostic products and services and molecular markers. The company develops, commercializes and provides molecular- and biomarker-based tests and services that enable physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor and inform cancer treatment. It also enables biotech and pharmaceutical companies to select candidate populations and reduce adverse drug reactions by providing information regarding genomic factors influencing subject responses to therapeutics. The company derives most of its revenue from the United States. http://www.cancergenetics.com

CGIX Earnings

EPS -0.31 P/E Ratio 0.00
Previous Earnings --
Latest Earnings --

CGIX Dividend

Dividend --
Ex-Date --
Pay Date --
History --

CGIX Charts

$0.20
52 Week Range
$1.26
Dec 10, 2018
Sep 21, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

0.23 0.01 0.00 0.00 CGIX NASDAQ -4.17 -8.00 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CGIX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CGIX&exchange=NASDAQ&chart=1

Check-Cap Ltd

CHEK $2.60
+0.01 (0.39%)

CHEK Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 20 Million
CHEK Description

Check-Cap Ltd is a clinical-stage medical diagnostics company. The company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. https://www.check-cap.com

CHEK Earnings

EPS -0.58 P/E Ratio 0.00
Previous Earnings --
Latest Earnings --

CHEK Dividend

Dividend --
Ex-Date --
Pay Date --
History --

CHEK Charts

$1.90
52 Week Range
$14.87
Feb 27, 2019
Apr 24, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

2.60 0.02 0.00 0.00 CHEK NASDAQ 0.39 14.54 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CHEK&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CHEK&exchange=NASDAQ&chart=1

Co-Diagnostics Inc

CODX $1.01
-0.03 (-2.88%)

CODX Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 20 Million
CODX Description

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company's diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests. http://www.codiagnostics.com

CODX Earnings

EPS -0.15 P/E Ratio 0.00
Previous Earnings --
Latest Earnings --

CODX Dividend

Dividend --
Ex-Date --
Pay Date --
History --

CODX Charts

$0.96
52 Week Range
$5.28
Jan 24, 2019
Jun 5, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

1.01 0.02 0.00 0.00 CODX NASDAQ -2.88 -34.84 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CODX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CODX&exchange=NASDAQ&chart=1

Charles River Laboratories International Inc

CRL $135.93
-0.11 (-0.08%)

CRL Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 6.59 Billion
CRL Description

Charles River Laboratories is a leading provider of drug discovery and development services. With roughly 50% of market share worldwide, the research model and services segment is the leading provider of animal models for laboratory testing. About half of the company's revenue comes from drug discovery and preclinical testing, and one fourth comes from the manufacturing support segment. http://www.criver.com

CRL Earnings

EPS 1.24 P/E Ratio 31.21
Previous Earnings Wed, Feb 13, 2019
Latest Earnings Tue, May 7, 2019 (In 13 days)

CRL Dividend

Dividend --
Ex-Date --
Pay Date --
History --

CRL Charts

$103.73
52 Week Range
$148.55
May 16, 2018
Apr 3, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

135.93 6.59 31.21 0.00 CRL NYSE -0.08 22.36 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CRL&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CRL&exchange=NYSE&chart=1

CytoSorbents Corp

CTSO $7.06
-0.01 (-0.14%)

CTSO Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 230 Million
CTSO Description

CytoSorbents Corp is a critical care immunotherapy company. It investigates and commercializes its blood purification technology to reduce uncontrolled inflammation in hospitalized patients internationally with the goal of preventing and treating multiple organ failure in life-threatening illnesses and cardiac surgery. Its product portfolio consists of Cytosord, Contrastsorb, Vetresq, Hemodefend and Drugsorb. The company's intellectual property consists of composition of matter, materials, methods of production, systems incorporating the technology and multiple medical uses. It derives its revenue from product sales and grants. https://www.cytosorbents.com

CTSO Earnings

EPS -0.17 P/E Ratio 0.00
Previous Earnings Tue, Nov 6, 2018
Latest Earnings Thu, Mar 7, 2019 (48 days ago)

CTSO Dividend

Dividend --
Ex-Date --
Pay Date --
History --

CTSO Charts

$6.82
52 Week Range
$14.80
Jan 24, 2019
Sep 4, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

7.06 0.23 0.00 0.00 CTSO NASDAQ -0.14 -10.06 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CTSO&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=CTSO&exchange=NASDAQ&chart=1

DarioHealth Corp

DRIO $0.72
-0.02 (-2.14%)

DRIO Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 30 Million
DRIO Description

DarioHealth Corp is a digital health company. It is engaged in the development and commercialization of patented and proprietary technology that provides consumers with laboratory-testing capabilities using smartphones and other mobile devices. The company's product, Dario Smart Meter is a mobile, real-time, cloud-based, diabetes management solution based on a multi-featured software application combined with a blood glucose monitoring device. The group operates internationally and derives revenues from the sale of its Dario smart meter and related device-specific disposables test strip cartridges and lancets. https://www.mydario.com

DRIO Earnings

EPS -0.11 P/E Ratio 0.00
Previous Earnings --
Latest Earnings --

DRIO Dividend

Dividend --
Ex-Date --
Pay Date --
History --

DRIO Charts

$0.65
52 Week Range
$1.86
Feb 8, 2019
Apr 25, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

0.72 0.03 0.00 0.00 DRIO NASDAQ -2.14 -5.26 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=DRIO&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=DRIO&exchange=NASDAQ&chart=1

DexCom Inc

DXCM $119.38
+1.35 (1.14%)

DXCM Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 10.43 Billion
DXCM Description

Dexcom designs and commercializes continuous glucose monitoring (CGM) systems for diabetics. CGM systems serve as an alternative to the traditional glucometer process, and the company sells three different pieces of equipment, a sensor, a transmitter, and a receiver. http://www.dexcom.com

DXCM Earnings

EPS -2.03 P/E Ratio 253.35
Previous Earnings Thu, Feb 21, 2019
Latest Earnings Wed, May 1, 2019 (In 7 days)

DXCM Dividend

Dividend --
Ex-Date --
Pay Date --
History --

DXCM Charts

$73.18
52 Week Range
$152.73
Apr 30, 2018
Feb 12, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

119.38 10.43 253.35 0.00 DXCM NASDAQ 1.14 3.65 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=DXCM&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=DXCM&exchange=NASDAQ&chart=1

Enzo Biochem Inc

ENZ $3.62
-0.05 (-1.10%)

ENZ Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 170 Million
ENZ Description

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment. http://www.enzo.com

ENZ Earnings

EPS -0.18 P/E Ratio 0.00
Previous Earnings Mon, Dec 10, 2018
Latest Earnings Mon, Mar 11, 2019 (44 days ago)

ENZ Dividend

Dividend --
Ex-Date --
Pay Date --
History --

ENZ Charts

$2.46
52 Week Range
$6.78
Dec 20, 2018
May 17, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

3.62 0.17 0.00 0.00 ENZ NYSE -1.10 28.93 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ENZ&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ENZ&exchange=NYSE&chart=1

Exact Sciences Corp

EXAS $95.74
+1.80 (1.92%)

EXAS Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 11.60 Billion
EXAS Description

Exact Sciences is a molecular diagnostics company focused on the early detection and prevention of certain types of cancer. Its core product is a noninvasive screening test, Cologuard, which analyzes stool-based DNA samples to detect the precancerous and early stages of colorectal cancer. The test includes DNA markers and a protein marker that can detect blood in the stool. Exact Sciences receives revenue from two sources: laboratory services and licensing fees. Its laboratory services revenue is generated by diagnostic services that use the Cologuard test. Exact Sciences also receives revenue from the licensing of its product rights. http://www.exactsciences.com

EXAS Earnings

EPS -0.44 P/E Ratio 0.00
Previous Earnings Thu, Feb 21, 2019
Latest Earnings Tue, Apr 30, 2019 (In 6 days)

EXAS Dividend

Dividend --
Ex-Date --
Pay Date --
History --

EXAS Charts

$45.27
52 Week Range
$96.50
Apr 25, 2018
Feb 27, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

95.74 11.60 0.00 0.00 EXAS NASDAQ 1.92 48.80 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=EXAS&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=EXAS&exchange=NASDAQ&chart=1

Fluidigm Corp

FLDM $13.27
+0.13 (0.99%)

FLDM Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 890 Million
FLDM Description

Fluidigm Corp manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. These tools are based on microfluidics and mass cytometry technologies. It sells instruments and consumables, including integrated fluidic circuits, assays, and reagents. Slightly more than half of the firm's revenue comes from the sale of Consumables. Fluidigm primarily sells its products to academic institutions, clinical laboratories, and biopharmaceutical companies. The majority of revenue is generated in the United States followed by EMEA and Asia-Pacific. http://www.fluidigm.com

FLDM Earnings

EPS -0.36 P/E Ratio 0.00
Previous Earnings Thu, Feb 7, 2019
Latest Earnings Thu, May 2, 2019 (In 8 days)

FLDM Dividend

Dividend --
Ex-Date --
Pay Date --
History --

FLDM Charts

$4.86
52 Week Range
$14.36
Jun 18, 2018
Mar 20, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

13.27 0.89 0.00 0.00 FLDM NASDAQ 0.99 54.48 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=FLDM&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=FLDM&exchange=NASDAQ&chart=1

Fulgent Genetics Inc

FLGT $7.37
-0.13 (-1.73%)

FLGT Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 120 Million
FLGT Description

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to a disease and enhanced disease treatment and prognosis. https://www.fulgentgenetics.com

FLGT Earnings

EPS -0.05 P/E Ratio 0.00
Previous Earnings Thu, Feb 28, 2019
Latest Earnings Tue, May 7, 2019 (In 13 days)

FLGT Dividend

Dividend --
Ex-Date --
Pay Date --
History --

FLGT Charts

$3.12
52 Week Range
$7.50
Nov 19, 2018
Apr 23, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

7.37 0.12 0.00 0.00 FLGT NASDAQ -1.73 111.78 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=FLGT&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=FLGT&exchange=NASDAQ&chart=1

Genetic Technologies Ltd - American Depositary Shares representing 150 ordinary shares

GENE $0.80
+0.01 (1.27%)

GENE Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 10 Million
GENE Description

Genetic Technologies Ltd is an Australia-based molecular diagnostics company which offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. http://www.gtglabs.com

GENE Earnings

EPS -0.33 P/E Ratio 0.00
Previous Earnings --
Latest Earnings --

GENE Dividend

Dividend --
Ex-Date --
Pay Date --
History --

GENE Charts

$0.51
52 Week Range
$1.48
Dec 20, 2018
Jul 16, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

0.80 0.01 0.00 0.00 GENE NASDAQ 1.27 23.08 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=GENE&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=GENE&exchange=NASDAQ&chart=1

Guardant Health Inc

GH $66.75
+0.03 (0.04%)

GH Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 6.06 Billion
GH Description

Guardant Health Inc is a precision oncology company. It is focused on helping conquer cancer globally through the use of proprietary blood tests, vast data sets, and advanced analytics. The company only reportable segment: delivering precision oncology testing and development services. Geographically, the company generates a majority of its revenue from the United States. its solutions include treatment selection, recurrence, and early detection. https://www.guardanthealth.com

GH Earnings

EPS -2.08 P/E Ratio 0.00
Previous Earnings Mon, Nov 19, 2018
Latest Earnings Tue, Mar 12, 2019 (43 days ago)

GH Dividend

Dividend --
Ex-Date --
Pay Date --
History --

GH Charts

$29.20
52 Week Range
$97.98
Oct 5, 2018
Mar 15, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

66.75 6.06 0.00 0.00 GH NASDAQ 0.04 82.88 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=GH&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=GH&exchange=NASDAQ&chart=1

Genomic Health Inc

GHDX $65.69
-0.25 (-0.37%)

GHDX Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 2.41 Billion
GHDX Description

Genomic Health Inc is a healthcare company. It provides genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer. Genomic offers the tissue-based invasive breast, DCIS, prostate, and colon Oncotype DX tests as clinical laboratory services. The company operates in one business segment, which primarily focuses on the development and global commercialization of genomic-based clinical laboratory services. Genomic derives most of its revenue from the United States. http://www.genomichealth.com

GHDX Earnings

EPS 0.25 P/E Ratio 142.82
Previous Earnings Tue, Nov 6, 2018
Latest Earnings Wed, Feb 20, 2019 (63 days ago)

GHDX Dividend

Dividend --
Ex-Date --
Pay Date --
History --

GHDX Charts

$31.35
52 Week Range
$90.18
Apr 24, 2018
Nov 7, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

65.69 2.41 142.82 0.00 GHDX NASDAQ -0.37 5.61 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=GHDX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=GHDX&exchange=NASDAQ&chart=1

Heska Corp

HSKA $77.66
+1.55 (2.04%)

HSKA Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 580 Million
HSKA Description

Heska Corp is engaged in developing, manufacturing, marketing, selling & supporting veterinary products. The company's segments are Core Companion Animal Health & Other Vaccines, Pharmaceuticals and Products. The CCA segment includes, primarily for canine & feline use, a point of care laboratory instruments & supplies, digital imaging products, software & services, local & cloud-based data services, allergy testing & immunotherapy, & single-use offerings such as point of care diagnostic tests and heartworm preventive products. The OVP segment includes private label vaccine and pharmaceutical production, primarily for cattle but also for other species including equine, porcine, avian, feline & canine. http://www.heska.com

HSKA Earnings

EPS 0.47 P/E Ratio 651.07
Previous Earnings Tue, Feb 26, 2019
Latest Earnings Tue, May 7, 2019 (In 13 days)

HSKA Dividend

Dividend --
Ex-Date --
Pay Date --
History --

HSKA Charts

$73.40
52 Week Range
$113.31
Apr 17, 2019
Sep 28, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

77.66 0.58 651.07 0.00 HSKA NASDAQ 2.04 -14.24 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=HSKA&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=HSKA&exchange=NASDAQ&chart=1

HTG Molecular Diagnostics Inc

HTGM $2.58
+0.01 (0.39%)

HTGM Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 70 Million
HTGM Description

HTG Molecular Diagnostics Inc is a commercial stage company that develops and markets products and services based on proprietary technology that facilitates the routine use of targeted molecular profiling. Molecular profiling is the collection of information about multiple molecular targets, such as DNA and RNA, also called biomarkers, in a biological sample. Molecular profiling information has many important applications, from basic research to molecular diagnostics in personalized medicine. The company derives revenue from services provided by its VERI/O laboratory and sales of the company's automation systems and integrated next-generation sequencing-based HTG EdgeSeq assays. It operates in one segment and its customers are primarily located in the United States. https://www.htgmolecular.com

HTGM Earnings

EPS -0.07 P/E Ratio 0.00
Previous Earnings Thu, Nov 8, 2018
Latest Earnings Thu, Mar 7, 2019 (48 days ago)

HTGM Dividend

Dividend --
Ex-Date --
Pay Date --
History --

HTGM Charts

$2.10
52 Week Range
$5.34
Jan 29, 2019
Sep 27, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

2.58 0.07 0.00 0.00 HTGM NASDAQ 0.39 -4.44 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=HTGM&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=HTGM&exchange=NASDAQ&chart=1

Icon PLC

ICLR $135.58
+0.53 (0.39%)

ICLR Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 7.02 Billion
ICLR Description

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland. http://www.iconplc.com

ICLR Earnings

EPS 1.63 P/E Ratio 23.25
Previous Earnings Wed, Oct 24, 2018
Latest Earnings Wed, Feb 20, 2019 (63 days ago)

ICLR Dividend

Dividend --
Ex-Date --
Pay Date --
History --

ICLR Charts

$117.26
52 Week Range
$153.75
May 2, 2018
Sep 28, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

135.58 7.02 23.25 0.00 ICLR NASDAQ 0.39 6.14 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ICLR&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ICLR&exchange=NASDAQ&chart=1

Interpace Diagnostics Group Inc

IDXG $0.76
+0.01 (1.33%)

IDXG Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 30 Million
IDXG Description

Interpace Diagnostics Group Inc is a United States-based integrated commercial and bioinformatics company. It is engaged in developing and commercializing molecular diagnostic tests, leveraging the technology and personalized medicine for patient diagnosis and management. The company has four commercialized molecular tests, PancraGen for the diagnosis and prognosis of pancreatic cancer from pancreatic cysts, ThyGenX, for the diagnosis of thyroid cancer from thyroid nodules utilizing a next-generation sequencing assay and, ThyraMIR for the diagnosis of thyroid cancer from thyroid nodules utilizing a proprietary gene expression assay, and RespriDX for assessing metastatic versus primary lung cancer tumors. The company's customers consist of physicians, hospitals, and clinics. http://www.interpacediagnostics.com

IDXG Earnings

EPS -0.14 P/E Ratio 0.00
Previous Earnings Tue, Nov 13, 2018
Latest Earnings Tue, Mar 19, 2019 (36 days ago)

IDXG Dividend

Dividend --
Ex-Date --
Pay Date --
History --

IDXG Charts

$0.69
52 Week Range
$1.68
Apr 18, 2019
Sep 19, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

0.76 0.03 0.00 0.00 IDXG NASDAQ 1.33 -16.48 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=IDXG&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=IDXG&exchange=NASDAQ&chart=1

iKang Healthcare Group Inc

KANG $20.53
-0.01 (-0.05%)

KANG Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 1.43 Billion
KANG Description

iKang Healthcare Group Inc provides preventive healthcare solutions including a wide range of medical examinations services and value-added services including disease screening, dental services, and other services in China. The company's segments include Medical examinations and other Medical services, and Dental services. Medical examinations; which normally cover internal, gynecology, ophthalmology, ENT, dental, lab tests, electrocardiogram, ultrasound, and X-ray. Its Value-added services include disease screening focusing on cancer screening, cardiovascular disease screening, certain chronic disease screening and dental testing including oral health, pediatric and cosmetic dentistry. Most of the firm revenue is generated from the Medical examinations segment. http://www.ikanggroup.com

KANG Earnings

EPS 0.23 P/E Ratio 0.00
Previous Earnings --
Latest Earnings Thu, Sep 27, 2018 (209 days ago)

KANG Dividend

Dividend --
Ex-Date --
Pay Date --
History --

KANG Charts

$15.48
52 Week Range
$20.90
Nov 13, 2018
Aug 2, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

20.53 1.43 0.00 0.00 KANG NASDAQ -0.05 0.74 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=KANG&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=KANG&exchange=NASDAQ&chart=1

Lantheus Holdings Inc

LNTH $24.96
+0.13 (0.52%)

LNTH Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 930 Million
LNTH Description

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in diagnostic procedures, such as cardiac ultrasounds, or echocardiograms, x-ray imaging used by physicians to progress the clarity of the diagnostic image. The company's portfolio of imaging products includes medical radiopharmaceuticals such as DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, and Neurolite. Its revenue is generated from the sales of diagnostic imaging agents to wholesalers, distributors radiopharmacies and directly to hospitals and clinics predominantly in the United States. http://www.lantheus.com

LNTH Earnings

EPS 0.35 P/E Ratio 24.27
Previous Earnings Tue, Feb 19, 2019
Latest Earnings Tue, Apr 30, 2019 (In 6 days)

LNTH Dividend

Dividend --
Ex-Date --
Pay Date --
History --

LNTH Charts

$12.68
52 Week Range
$25.66
Oct 29, 2018
Apr 5, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

24.96 0.93 24.27 0.00 LNTH NASDAQ 0.52 61.34 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=LNTH&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=LNTH&exchange=NASDAQ&chart=1

Medpace Holdings Inc

MEDP $57.60
+0.27 (0.47%)

MEDP Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 1.94 Billion
MEDP Description

Medpace Holdings Inc is a clinical contract research organization. It is engaged in scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. It operates in North America, Europe, Africa, Middle East, Asia-Pacific and Latin America. http://www.medpace.com

MEDP Earnings

EPS 0.63 P/E Ratio 25.04
Previous Earnings Mon, Feb 25, 2019
Latest Earnings Mon, Apr 29, 2019 (In 5 days)

MEDP Dividend

Dividend --
Ex-Date --
Pay Date --
History --

MEDP Charts

$36.42
52 Week Range
$70.58
May 3, 2018
Feb 25, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

57.60 1.94 25.04 0.00 MEDP NASDAQ 0.47 9.43 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MEDP&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MEDP&exchange=NASDAQ&chart=1

Miragen Therapeutics, Inc. - Common Stock

MGEN $2.88
-0.04 (-1.37%)

MGEN Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 80 Million
MGEN Description

Miragen Therapeutics Inc is a US-based clinical-stage biopharmaceutical company discovering and developing proprietary RNA (Ribonucleic acid)-targeted therapeutics. The company's main product candidates, MRG-106, MRG-201, MRG-107, and MRG-110. MRG-106 and MRG-201 are currently in Phase 1 clinical trials. The company mainly focuses on developing such therapeutics which will target blood cancers, pathological fibrosis, and revascularization. http://www.miragen.com

MGEN Earnings

EPS -0.33 P/E Ratio 0.00
Previous Earnings Wed, Nov 7, 2018
Latest Earnings Wed, Mar 13, 2019 (42 days ago)

MGEN Dividend

Dividend --
Ex-Date --
Pay Date --
History --

MGEN Charts

$2.32
52 Week Range
$7.71
Mar 8, 2019
May 14, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

2.88 0.08 0.00 0.00 MGEN NASDAQ -1.37 -14.29 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MGEN&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MGEN&exchange=NASDAQ&chart=1

Motus GI Holdings Inc

MOTS $4.15
+0.02 (0.48%)

MOTS Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 80 Million
MOTS Description

Motus GI Holdings Inc is a medical technology company dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The company is focused on the development and commercialization of the Pure-Vu System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. https://www.motusgi.com

MOTS Earnings

EPS -0.34 P/E Ratio 0.00
Previous Earnings Wed, Nov 14, 2018
Latest Earnings Wed, Mar 27, 2019 (28 days ago)

MOTS Dividend

Dividend --
Ex-Date --
Pay Date --
History --

MOTS Charts

$2.62
52 Week Range
$9.69
Dec 21, 2018
Jul 6, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

4.15 0.08 0.00 0.00 MOTS NASDAQ 0.48 23.88 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MOTS&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MOTS&exchange=NASDAQ&chart=1

Myriad Genetics Inc

MYGN $32.31
-0.14 (-0.43%)

MYGN Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 2.33 Billion
MYGN Description

Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease or tailor treatment for already diagnosed patients. The firm produces myRisk, a 28-gene panel with the capability to identify the elevated risk of developing eight types of cancer. Other diagnostic products include BRACAnalysis CDx, GeneSight, Vectra DA, and Prolaris. The firm also offers biomarker discovery and companion diagnostic services to pharmaceutical and biotechnology companies. http://www.myriad.com

MYGN Earnings

EPS 0.04 P/E Ratio 106.83
Previous Earnings Tue, Nov 6, 2018
Latest Earnings Tue, Feb 5, 2019 (78 days ago)

MYGN Dividend

Dividend --
Ex-Date --
Pay Date --
History --

MYGN Charts

$26.93
52 Week Range
$50.34
Feb 1, 2019
Sep 4, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

32.31 2.33 106.83 0.00 MYGN NASDAQ -0.43 11.41 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MYGN&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MYGN&exchange=NASDAQ&chart=1

MYnd Analytics, Inc. - Common Stock

MYND $1.20
-0.04 (-3.23%)

MYND Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 10 Million
MYND Description

MYnd Analytics Inc is a predictive analytics company. It mainly focuses on developing a decision support tool to help physicians reduce trial and error treatment in mental health and provide more personalized care to patients. The company provides objective clinical decision support to mental health care providers for the personalized treatment of behavioral disorders, including depression, anxiety, bipolar disorder, post-traumatic stress disorder (PTSD) and other non-psychotic disorders. In addition, the company also develops a proprietary neurometric platform, PEER Online to generate Psychiatric EEG Evaluation Registry (PEER) Reports predicting the likelihood of response by an individual to a range of medications prescribed for the treatment of behavioral disorders. http://www.myndanalytics.com

MYND Earnings

EPS -0.32 P/E Ratio 0.00
Previous Earnings --
Latest Earnings --

MYND Dividend

Dividend --
Ex-Date --
Pay Date --
History --

MYND Charts

$0.67
52 Week Range
$3.32
Dec 24, 2018
May 18, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

1.20 0.01 0.00 0.00 MYND NASDAQ -3.23 62.16 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MYND&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=MYND&exchange=NASDAQ&chart=1

ENDRA Life Sciences Inc

NDRA $1.54
+0.01 (0.65%)

NDRA Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 10 Million
NDRA Description

ENDRA Life Sciences Inc develops diagnostics and research products supported by ultrasound technology in the United States. Its products are used in various applications to enhance the audible performance of the ultrasound technology in medical devices. ENDRA's products are applied for varied purposes including the Nexus 128 pre-clinical and Thermo-Acoustic Enhanced Ultrasound clinical applications such as molecular probe uptake, quantitative tumor imaging, hepatic steatosis and vessel imaging. https://endrainc.com

NDRA Earnings

EPS -0.28 P/E Ratio 0.00
Previous Earnings --
Latest Earnings --

NDRA Dividend

Dividend --
Ex-Date --
Pay Date --
History --

NDRA Charts

$1.50
52 Week Range
$5.40
Dec 31, 2018
Oct 30, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

1.54 0.01 0.00 0.00 NDRA NASDAQ 0.65 -12.00 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=NDRA&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=NDRA&exchange=NASDAQ&chart=1

NeoGenomics Inc

NEO $19.98
-0.19 (-0.94%)

NEO Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 1.86 Billion
NEO Description

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services. http://www.neogenomics.com

NEO Earnings

EPS 0.00 P/E Ratio 195.75
Previous Earnings Tue, Feb 19, 2019
Latest Earnings Tue, Apr 30, 2019 (In 6 days)

NEO Dividend

Dividend --
Ex-Date --
Pay Date --
History --

NEO Charts

$9.39
52 Week Range
$21.92
Apr 24, 2018
Apr 10, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

19.98 1.86 195.75 0.00 NEO NASDAQ -0.94 59.33 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=NEO&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=NEO&exchange=NASDAQ&chart=1

Neogen Corp

NEOG $57.91
+0.27 (0.47%)

NEOG Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 2.94 Billion
NEOG Description

Neogen Corp develops and markets a range of products related to food and animal safety. Its food safety segment sells diagnostic test kits to food producers and processors that detect harmful substances in human food and animal feed, like foodborne pathogens, natural toxins, food allergens, and pesticide residues. Most of these tests are disposable products. The animal safety segment manufactures pharmaceuticals, vaccines, veterinary instruments, rodenticides, and insecticides for the animal safety market. These products are largely used by the veterinary and agricultural industries. The animal safety segment generates over half of Neogen's revenue. The firm's customers are primarily located in the United States. http://www.neogen.com

NEOG Earnings

EPS 0.25 P/E Ratio 47.47
Previous Earnings Thu, Dec 20, 2018
Latest Earnings Tue, Mar 26, 2019 (29 days ago)

NEOG Dividend

Dividend --
Ex-Date --
Pay Date --
History --

NEOG Charts

$52.72
52 Week Range
$96.50
Dec 24, 2018
Sep 14, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

57.91 2.94 47.47 0.00 NEOG NASDAQ 0.47 1.76 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=NEOG&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=NEOG&exchange=NASDAQ&chart=1

National Research Corp

NRC $39.79
-0.07 (-0.18%)

NRC Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 970 Million
NRC Description

National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations and payers across a range of mission-critical, constituent-related elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement. It operates in the US and Canada, of which key revenue is derived from the US. http://www.nationalresearch.com

NRC Earnings

EPS 1.90 P/E Ratio 31.30
Previous Earnings --
Latest Earnings --

NRC Dividend

Dividend --
Ex-Date Fri, Dec 28, 2018 (117 days ago)
Pay Date Tue, Jan 15, 2019
History 19 Payments (Quarterly)

NRC Charts

$32.70
52 Week Range
$40.00
Apr 30, 2018
Feb 19, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

39.79 0.97 31.30 0.00 NRC NASDAQ -0.18 3.89 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=NRC&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=NRC&exchange=NASDAQ&chart=1

Natera Inc

NTRA $18.97
-0.04 (-0.16%)

NTRA Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 1.15 Billion
NTRA Description

Natera Inc is operative in the healthcare field in the United States. Its core business is to offer invasive and other means of diagnosing genetic features of a fetus. Natera's array of diagnostic services include Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Anora Products of Conception (POC) test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing (PAT), to determine paternity by studying the fragments of fetal deoxyribonucleic acid (DNA) in a pregnant mother's blood and a blood sample from the alleged father. The Company acquires its revenue by billing an insurance carrier, a clinic or a patient for the test upon delivery of the test result. http://www.natera.com

NTRA Earnings

EPS -0.51 P/E Ratio 0.00
Previous Earnings Thu, Nov 8, 2018
Latest Earnings Tue, Mar 12, 2019 (43 days ago)

NTRA Dividend

Dividend --
Ex-Date --
Pay Date --
History --

NTRA Charts

$10.95
52 Week Range
$28.96
Apr 24, 2018
Aug 24, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

18.97 1.15 0.00 0.00 NTRA NASDAQ -0.16 46.41 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=NTRA&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=NTRA&exchange=NASDAQ&chart=1

Invitae Corp

NVTA $23.67
+0.04 (0.17%)

NVTA Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 1.75 Billion
NVTA Description

Invitae Corp operates as a genetic information company in diagnostic and research industry. The company's tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders and other hereditary conditions. https://www.invitae.com

NVTA Earnings

EPS -0.40 P/E Ratio 0.00
Previous Earnings Wed, Nov 7, 2018
Latest Earnings Tue, Feb 19, 2019 (64 days ago)

NVTA Dividend

Dividend --
Ex-Date --
Pay Date --
History --

NVTA Charts

$5.40
52 Week Range
$26.27
May 3, 2018
Apr 10, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

23.67 1.75 0.00 0.00 NVTA NYSE 0.17 109.28 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=NVTA&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=NVTA&exchange=NYSE&chart=1

Organovo Holdings Inc

ONVO $1.01
0.00 (0.00%)

ONVO Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 120 Million
ONVO Description

Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels. http://www.organovo.com

ONVO Earnings

EPS -0.06 P/E Ratio 0.00
Previous Earnings Thu, Nov 8, 2018
Latest Earnings Thu, Feb 7, 2019 (76 days ago)

ONVO Dividend

Dividend --
Ex-Date --
Pay Date --
History --

ONVO Charts

$0.93
52 Week Range
$1.99
Dec 24, 2018
May 23, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

1.01 0.12 0.00 0.00 ONVO NASDAQ 0.00 1.00 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ONVO&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ONVO&exchange=NASDAQ&chart=1

OpGen Inc

OPGN $0.54
-0.01 (-1.82%)

OPGN Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 10 Million
OPGN Description

OpGen Inc is part of the diagnostic and research industry. The company is engaged in developing molecular information solutions to combat infectious disease in global healthcare settings. It helps to guide clinicians with information about life-threatening infections, managing patient outcomes, and the spread of infections caused by multidrug-resistant microorganisms. OpGen is working to deliver its molecular information solution to a global network of customers and partners. The company's high-resolution DNA tests are marketed under the Acuitas trade name. http://www.opgen.com

OPGN Earnings

EPS -0.47 P/E Ratio 0.00
Previous Earnings --
Latest Earnings --

OPGN Dividend

Dividend --
Ex-Date --
Pay Date --
History --

OPGN Charts

$0.55
52 Week Range
$2.80
Apr 22, 2019
Jun 11, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

0.54 0.01 0.00 0.00 OPGN NASDAQ -1.82 -62.24 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=OPGN&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=OPGN&exchange=NASDAQ&chart=1

Oxford Immunotec Global PLC

OXFD $16.20
+0.19 (1.19%)

OXFD Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 420 Million
OXFD Description

Oxford Immunotec Global PLC is a diagnostic company. It is focused on developing and commercializing proprietary tests for the management of underserved immune regulated conditions. Its products include T-spot TB, T-spot-CMV, T-spot PRT,T-cell extend etc. The company's research and development activities focus on Chronic infections, Transplantation, Autoimmune and Inflammatory disease, Immune oncology. http://www.oxfordimmunotec.com

OXFD Earnings

EPS 5.38 P/E Ratio 0.00
Previous Earnings Fri, Nov 9, 2018
Latest Earnings Mon, Mar 11, 2019 (44 days ago)

OXFD Dividend

Dividend --
Ex-Date --
Pay Date --
History --

OXFD Charts

$11.87
52 Week Range
$18.33
Jul 30, 2018
Mar 14, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

16.20 0.42 0.00 0.00 OXFD NASDAQ 1.19 24.71 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=OXFD&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=OXFD&exchange=NASDAQ&chart=1

Pacific Biosciences of California Inc

PACB $7.33
-0.04 (-0.54%)

PACB Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 1.10 Billion
PACB Description

Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. The company develops sequencing systems to assist in resolving genetically complex problems. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The majority of the company's revenue is derived from North America, followed by Asia and Europe. http://www.pacb.com

PACB Earnings

EPS -0.21 P/E Ratio 0.00
Previous Earnings Thu, Nov 1, 2018
Latest Earnings Mon, Feb 11, 2019 (72 days ago)

PACB Dividend

Dividend --
Ex-Date --
Pay Date --
History --

PACB Charts

$2.31
52 Week Range
$7.82
May 4, 2018
Nov 30, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

7.33 1.10 0.00 0.00 PACB NASDAQ -0.54 -0.95 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PACB&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PACB&exchange=NASDAQ&chart=1

Koninklijke Philips N.V. NY Registry Shares

PHG $40.07
-0.30 (-0.74%)

PHG Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 36.35 Billion
PHG Description

Philips is a diversified global manufacturer operating in two segments: healthtech and personal health. About 60% of the company's revenue comes from the healthtech segment, which features imaging systems, ultrasound equipment, patient monitoring systems, and image-guided therapy solutions. Personal health products like domestic appliances, health and wellness, and personal care contribute the remainder of Philips' turnover. In 2017, Philips generated EUR 17.8 billion of sales and had 105,000 employees in over 100 countries. http://www.philips.com

PHG Earnings

EPS 0.73 P/E Ratio 25.32
Previous Earnings Tue, Jan 29, 2019
Latest Earnings Mon, Apr 29, 2019 (In 5 days)

PHG Dividend

Dividend 2.47% / $0.99
Ex-Date Mon, May 7, 2018 (352 days ago)
Pay Date Wed, Jun 6, 2018
History 40 Payments (Annually)

PHG Charts

$33.04
52 Week Range
$46.37
Jan 3, 2019
Sep 26, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

40.07 36.35 25.32 2.47 PHG NYSE -0.74 15.44 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PHG&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PHG&exchange=NYSE&chart=1

Psychemedics Corp

PMD $12.30
-1.45 (-10.55%)

PMD Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 80 Million
PMD Description

Psychemedics Corp is a US-based company which provides testing services for the detection of drugs of abuse through the analysis of hair samples. The core business of the company is performing drug testing and reporting the results. Its drug testing services include training for collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit tested of samples. The company also provides testimony to support the results of the tests. The testing methods of the company utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The company operates through the single segment being Drug testing services. http://www.psychemedics.com

PMD Earnings

EPS 0.16 P/E Ratio 16.39
Previous Earnings Tue, Oct 23, 2018
Latest Earnings Mon, Mar 4, 2019 (51 days ago)

PMD Dividend

Dividend 5.83% / $0.72
Ex-Date Thu, Nov 1, 2018 (174 days ago)
Pay Date Mon, Nov 12, 2018
History 90 Payments (Quarterly)

PMD Charts

$12.35
52 Week Range
$21.72
New Low Today
Aug 9, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

12.30 0.08 16.39 5.83 PMD NASDAQ -10.55 -23.84 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PMD&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PMD&exchange=NASDAQ&chart=1

PRA Health Sciences Inc

PRAH $96.37
+0.44 (0.46%)

PRAH Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 6.17 Billion
PRAH Description

PRA Health Sciences is a global contract research organization that provides drug development and clinical trial services to pharmaceutical and biotechnology firms. Its services run from early- to late-stage clinical trial outsourcing with varying levels of support, including one-off specialized staffing services to strategic partnerships where PRA handles nearly all aspects of the trial. In 2017, PRA acquired Symphony Health, a healthcare data and analytics provider. https://www.prahs.com

PRAH Earnings

EPS 1.10 P/E Ratio 47.85
Previous Earnings Wed, Feb 27, 2019
Latest Earnings Wed, May 1, 2019 (In 7 days)

PRAH Dividend

Dividend --
Ex-Date --
Pay Date --
History --

PRAH Charts

$79.95
52 Week Range
$116.74
May 17, 2018
Nov 30, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

96.37 6.17 47.85 0.00 PRAH NASDAQ 0.46 6.88 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PRAH&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PRAH&exchange=NASDAQ&chart=1

Precipio Inc

PRPO $0.48
0.00 (0.00%)

PRPO Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 40 Million
PRPO Description

Precipio Inc is a diagnostics company, which has built a platform designed to eradicate the problem of misdiagnosis by harnessing the expertise and technology developed within academic institutions and delivering diagnostic information to physicians. The company's platform delivers diagnostic accuracy through academic expertise and cutting-edge technology. It operates as a laboratory focused on delivering specialized diagnostic services to physicians and their patients to ensure they receive accurate results. http://www.precipiodx.com

PRPO Earnings

EPS -0.17 P/E Ratio 0.00
Previous Earnings --
Latest Earnings --

PRPO Dividend

Dividend --
Ex-Date --
Pay Date --
History --

PRPO Charts

$0.12
52 Week Range
$0.55
Mar 27, 2019
May 24, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

0.48 0.04 0.00 0.00 PRPO NASDAQ 0.00 200.00 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PRPO&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=PRPO&exchange=NASDAQ&chart=1

Quidel Corp

QDEL $62.91
+0.38 (0.61%)

QDEL Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 2.37 Billion
QDEL Description

Quidel Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. It is separated into four product categories: Rapid immunoassays, Cardiac immunoassays, Specialized diagnostic solutions and Molecular diagnostic solutions. Rapid immunoassay and Cardiac immunoassay tests for use in physician offices, hospital laboratories and emergency departments, retail clinics, eye health settings, pharmacies and other urgent care sites, Specialized diagnostic solutions, including direct fluorescent assays and culture-based tests, and Molecular diagnostic tests across a number of hospitals, moderately complex physician offices, laboratories and other segments. The company generates a majority of its revenue from the rapid immunoassays. http://www.quidel.com

QDEL Earnings

EPS 0.82 P/E Ratio 63.22
Previous Earnings Tue, Nov 6, 2018
Latest Earnings Wed, Feb 13, 2019 (70 days ago)

QDEL Dividend

Dividend --
Ex-Date --
Pay Date --
History --

QDEL Charts

$44.55
52 Week Range
$76.88
Dec 24, 2018
Aug 31, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

62.91 2.37 63.22 0.00 QDEL NASDAQ 0.61 29.47 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=QDEL&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=QDEL&exchange=NASDAQ&chart=1

Qiagen NV

QGEN $38.54
-0.19 (-0.49%)

QGEN Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 8.57 Billion
QGEN Description

Qiagen NV offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company operates in four segments: molecular diagnostics (approximately 49% of sales), academia (23%), pharmaceutical (19%), and applied testing (9%). Qiagen generates about 88% of its revenue from consumable sales and 12% from instrumentation. The Americas account for the largest portion of the firm's revenue (46%), followed by EMEA (33%) and Asia-Pacific (21%). Qiagen is headquartered in Venlo, Netherlands. http://www.qiagen.com

QGEN Earnings

EPS 0.27 P/E Ratio 89.76
Previous Earnings Mon, Feb 4, 2019
Latest Earnings Mon, May 6, 2019 (In 12 days)

QGEN Dividend

Dividend --
Ex-Date --
Pay Date --
History --

QGEN Charts

$32.37
52 Week Range
$41.39
Apr 25, 2018
Apr 10, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

38.54 8.57 89.76 0.00 QGEN NYSE -0.49 12.92 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=QGEN&exchange=NYSE&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=QGEN&exchange=NYSE&chart=1

Quotient Ltd

QTNT $7.97
-0.15 (-1.85%)

QTNT Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 530 Million
QTNT Description

Quotient Ltd is a commercial-stage diagnostics company. It is involved in the business of provision of tests with an initial focus on blood grouping and serological disease screening. The company develops and commercializes Mosaiq automation platform. Its product portfolio includes Red cell reagents, Antisera, Specialty products, Specialty kits etc. The firm operates in Edinburgh, Scotland, Eysins, Switzerland and Newton, Pennsylvania. It derives the majority of its revenue from the United States. http://www.quotientbd.com

QTNT Earnings

EPS -0.46 P/E Ratio 0.00
Previous Earnings Mon, Nov 5, 2018
Latest Earnings Thu, Jan 31, 2019 (83 days ago)

QTNT Dividend

Dividend --
Ex-Date --
Pay Date --
History --

QTNT Charts

$4.00
52 Week Range
$11.07
Apr 24, 2018
Feb 27, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

7.97 0.53 0.00 0.00 QTNT NASDAQ -1.85 27.52 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=QTNT&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=QTNT&exchange=NASDAQ&chart=1

RadNet Inc

RDNT $12.46
+0.04 (0.25%)

RDNT Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 610 Million
RDNT Description

RadNet Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The firm derives revenue from fees charged for the diagnostic imaging services performed at these centers. http://www.radnet.com

RDNT Earnings

EPS -0.15 P/E Ratio 19.64
Previous Earnings Fri, Nov 9, 2018
Latest Earnings Thu, Mar 14, 2019 (41 days ago)

RDNT Dividend

Dividend --
Ex-Date --
Pay Date --
History --

RDNT Charts

$10.03
52 Week Range
$16.26
Jan 3, 2019
Oct 16, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

12.46 0.61 19.64 0.00 RDNT NASDAQ 0.25 18.45 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=RDNT&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=RDNT&exchange=NASDAQ&chart=1

Soleno Therapeutics, Inc. - Common Stock

SLNO $2.05
+0.06 (2.65%)

SLNO Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 60 Million
SLNO Description

Soleno Therapeutics Inc is a healthcare service provider. It develops and commercializes diagnostics, devices, and therapeutics addressing unmet medical needs. It has a range of commercial products based on its proprietary technologies, including those which utilize precision metering of gas flow. Its product candidates comprise of Serenz Allergy Relief, or Serenz, which is a proprietary handheld device that delivers non-inhaled CO2 topically to the nasal mucosa. https://www.soleno.life

SLNO Earnings

EPS 0.01 P/E Ratio 0.00
Previous Earnings Thu, Nov 15, 2018
Latest Earnings Mon, Mar 18, 2019 (37 days ago)

SLNO Dividend

Dividend --
Ex-Date --
Pay Date --
History --

SLNO Charts

$1.35
52 Week Range
$3.10
Mar 14, 2019
Jun 22, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

2.05 0.06 0.00 0.00 SLNO NASDAQ 2.65 7.33 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=SLNO&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=SLNO&exchange=NASDAQ&chart=1

Surmodics Inc

SRDX $43.30
-0.03 (-0.06%)

SRDX Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 570 Million
SRDX Description

Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using our technology to provide solutions to a difficult medical device and diagnostic challenges. It has two reportable segments: Medical device unit and Vitro diagnostics unit. Surmodics derives most of its revenue from the Medical device segment. http://www.surmodics.com

SRDX Earnings

EPS 0.10 P/E Ratio 0.00
Previous Earnings Fri, Nov 9, 2018
Latest Earnings Wed, Jan 30, 2019 (84 days ago)

SRDX Dividend

Dividend --
Ex-Date --
Pay Date --
History --

SRDX Charts

$37.05
52 Week Range
$80.35
May 1, 2018
Sep 13, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

43.30 0.57 0.00 0.00 SRDX NASDAQ -0.06 -6.92 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=SRDX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=SRDX&exchange=NASDAQ&chart=1

Neuronetics Inc

STIM $16.33
+0.34 (2.13%)

STIM Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 280 Million
STIM Description

Neuronetics Inc is a commercial stage medical technology company. It is focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. The company's product the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. Geographically, it generates a majority of its revenue from the United States. https://www.neurostar.com

STIM Earnings

EPS -0.35 P/E Ratio 0.00
Previous Earnings Tue, Nov 6, 2018
Latest Earnings Tue, Mar 5, 2019 (50 days ago)

STIM Dividend

Dividend --
Ex-Date --
Pay Date --
History --

STIM Charts

$13.60
52 Week Range
$37.54
Jan 23, 2019
Sep 10, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

16.33 0.28 0.00 0.00 STIM NASDAQ 2.13 -16.60 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=STIM&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=STIM&exchange=NASDAQ&chart=1

Syneos Health, Inc. - Class A Common Stock

SYNH $46.82
-0.11 (-0.23%)

SYNH Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 4.74 Billion
SYNH Description

Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services. https://www.syneoshealth.com

SYNH Earnings

EPS 0.44 P/E Ratio 216.91
Previous Earnings Thu, Feb 28, 2019
Latest Earnings Thu, May 9, 2019 (In 15 days)

SYNH Dividend

Dividend --
Ex-Date --
Pay Date --
History --

SYNH Charts

$36.49
52 Week Range
$55.70
Dec 24, 2018
Feb 22, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

46.82 4.74 216.91 0.00 SYNH NASDAQ -0.23 18.92 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=SYNH&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=SYNH&exchange=NASDAQ&chart=1

Trinity Biotech PLC

TRIB $2.78
0.00 (0.00%)

TRIB Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 60 Million
TRIB Description

Trinity Biotech PLC is in the business of development, manufacture, and marketing of clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. It also provides raw materials to life sciences and research industries globally. It markets products under the brand names Unigold, Mardx, Premier, Immublot, EZ, Capita etc. The company derives the majority of its revenues from Americas segment. http://www.trinitybiotech.com

TRIB Earnings

EPS -1.15 P/E Ratio 31.83
Previous Earnings Tue, Oct 23, 2018
Latest Earnings Thu, Mar 7, 2019 (48 days ago)

TRIB Dividend

Dividend --
Ex-Date --
Pay Date --
History 5 Payments (Annually)

TRIB Charts

$2.14
52 Week Range
$5.08
Dec 21, 2018
Jul 16, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

2.78 0.06 31.83 0.00 TRIB NASDAQ 0.00 20.35 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=TRIB&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=TRIB&exchange=NASDAQ&chart=1

TrovaGene Inc

TROV $3.59
-0.27 (-6.86%)

TROV Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 20 Million
TROV Description

TrovaGene Inc is a US-based which focuses on the development and commercialization of a proprietary molecular genetic detection technology for use in pharmaceutical development, clinical research and medical testing across a variety of clinical disciplines, including oncology and virology. Its primary focus is to utilize its technology in measuring circulating tumor DNA (deoxyribonucleic acid) in urine and blood with its proprietary platforms and research. The company has developed Trover liquid biopsy tests for use by physicians, third-party clinical laboratories, and pharmaceutical companies. https://www.trovageneoncology.com

TROV Earnings

EPS -6.54 P/E Ratio 0.00
Previous Earnings --
Latest Earnings --

TROV Dividend

Dividend --
Ex-Date --
Pay Date --
History --

TROV Charts

$2.78
52 Week Range
$21.59
Feb 27, 2019
Apr 27, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

3.59 0.02 0.00 0.00 TROV NASDAQ -6.86 2.30 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=TROV&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=TROV&exchange=NASDAQ&chart=1

T2 Biosystems Inc

TTOO $2.64
0.00 (0.00%)

TTOO Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 110 Million
TTOO Description

T2 Biosystems Inc provides rapid in vitro diagnostic tests to hospitals and laboratories. Its core technology is the T2 Magnetic Resonance (T2MR) technology, which can detect a variety of molecular targets directly from whole blood. T2MR technology enables the T2Dx system, which is fully automated from patient sample to result for its panels focused on bacterial and fungal infections that could cause sepsis, and its pipeline panel for Lyme disease. http://www.t2biosystems.com

TTOO Earnings

EPS -0.35 P/E Ratio 0.00
Previous Earnings Thu, Mar 7, 2019
Latest Earnings Thu, May 2, 2019 (In 8 days)

TTOO Dividend

Dividend --
Ex-Date --
Pay Date --
History --

TTOO Charts

$2.52
52 Week Range
$9.58
Apr 18, 2019
Jun 15, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

2.64 0.11 0.00 0.00 TTOO NASDAQ 0.00 -25.21 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=TTOO&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=TTOO&exchange=NASDAQ&chart=1

Twist Bioscience Corp

TWST $33.19
+0.33 (1.01%)

TWST Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 850 Million
TWST Description

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilize proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable production of high-quality synthetic DNA faster and more affordable than ever before as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. https://www.twistbioscience.com

TWST Earnings

EPS -1.18 P/E Ratio 0.00
Previous Earnings Thu, Feb 7, 2019
Latest Earnings Tue, Apr 30, 2019 (In 6 days)

TWST Dividend

Dividend --
Ex-Date --
Pay Date --
History --

TWST Charts

$14.00
52 Week Range
$33.00
Oct 31, 2018
New High Today
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

33.19 0.85 0.00 0.00 TWST NASDAQ 1.01 34.91 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=TWST&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=TWST&exchange=NASDAQ&chart=1

Meridian Bioscience Inc

VIVO $12.88
+0.22 (1.74%)

VIVO Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 530 Million
VIVO Description

Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment contributes the majority of revenue & manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases. Its testing platforms include isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays. The Life sciences segment sells b-antigens, antibodies, and reagents in bulk to other diagnostic manufacturers, the agriculture industry, and researchers. It also manufactures proteins that biopharmaceutical companies use in new drugs and vaccines. The entity has a business presence in the US and other countries. http://www.meridianbioscience.com

VIVO Earnings

EPS 0.19 P/E Ratio 21.43
Previous Earnings Thu, Jan 24, 2019
Latest Earnings Tue, Apr 30, 2019 (In 6 days)

VIVO Dividend

Dividend 3.88% / $0.50
Ex-Date Fri, Nov 16, 2018 (159 days ago)
Pay Date Fri, Nov 30, 2018
History 116 Payments (Quarterly)

VIVO Charts

$12.49
52 Week Range
$19.72
Apr 17, 2019
Nov 9, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

12.88 0.53 21.43 3.88 VIVO NASDAQ 1.74 -23.56 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=VIVO&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=VIVO&exchange=NASDAQ&chart=1

Varex Imaging Corp

VREX $32.31
-0.07 (-0.22%)

VREX Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 1.22 Billion
VREX Description

Varex Imaging Corp designs and manufactures X-ray imaging components. The company operates in two segments Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital flat panel image detectors, high voltage connectors, ionization chambers, and buckys. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors and high voltage connectors. The company has manufacturing, research, and development operation in the United States, Europe, Philippines and China, and sales and service operations throughout the world. https://www.vareximaging.com

VREX Earnings

EPS 0.08 P/E Ratio 64.14
Previous Earnings Tue, Feb 5, 2019
Latest Earnings Tue, May 7, 2019 (In 13 days)

VREX Dividend

Dividend --
Ex-Date --
Pay Date --
History --

VREX Charts

$21.85
52 Week Range
$38.51
Dec 24, 2018
Jul 9, 2018
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

32.31 1.22 64.14 0.00 VREX NASDAQ -0.22 34.12 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=VREX&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=VREX&exchange=NASDAQ&chart=1

Vermillion Inc

VRML $1.29
-0.02 (-0.77%)

VRML Profile

Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 100 Million
VRML Description

Vermillion Inc is a diagnostic service and bio-analytic solutions provider company. It is engaged in the business of developing and commercializing diagnostic tests for the gynecologic disease. The company's products include OVA1, a blood test for the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor. It serves clinical reference laboratories, hospital laboratories, and physician offices. Geographically all the operations are functioned from the region of US. http://www.vermillion.com

VRML Earnings

EPS -0.04 P/E Ratio 0.00
Previous Earnings Thu, Nov 8, 2018
Latest Earnings Thu, Mar 28, 2019 (27 days ago)

VRML Dividend

Dividend --
Ex-Date --
Pay Date --
History --

VRML Charts

$0.29
52 Week Range
$1.44
Dec 26, 2018
Apr 15, 2019
Your notes, portfolio & ratings are not public.
Sign In. Sign Up.

1.29 0.10 0.00 0.00 VRML NASDAQ -0.77 285.29 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=VRML&exchange=NASDAQ&chart=5 https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=VRML&exchange=NASDAQ&chart=1

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy

/* Handling these symbols $DJI $DJT $DJU BF.B BRK.A BRK.B */ /* Handling these symbols $DJI $DJT $DJU BF.B BRK.A BRK.B */